How do participants in clinical trials compare with other patients with schizophrenia?

Freudenthal, Robert; Marston, Louise; Stansfeld, Jacki L; Priebe, Stefan; Moncrieff, Joanna

Freudenthal, Robert; Marston, Louise; Stansfeld, Jacki L; Priebe, Stefan; Moncrieff, Joanna.

Afiliación

Freudenthal R; Barnet Enfield Haringey Mental Health NHS Trust, UK.
Marston L; Research Department of Primary Care and Population Health, University College London, London, UK.
Stansfeld JL; Priment Clinical Trials Unit, University College London, London, UK.
Priebe S; Division of Psychiatry, University College London, London, UK.
Moncrieff J; Research & Development Department, Goodmayes Hospital, North East London NHS Foundation Trust, Essex, UK.

Contemp Clin Trials Commun ; 22: 100803, 2021 Jun.

Article en En | MEDLINE | ID: mdl-34195470

Palabras clave

Antipsychotics; Clinical trials; Psychosis; Schizophrenia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Contemp Clin Trials Commun Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google